HLVX

HLVX

USD

HilleVax Inc. Common Stock

$2.090-0.010 (-0.476%)

即時價格

Healthcare
生物科技
美國

價格圖表

無可用圖表數據

關鍵指標

市場指標
公司基本面
交易統計

市場指標

開盤

$2.100

最高

$2.090

最低

$2.090

交易量

N/A

公司基本面

市值

104.8M

行業

生物科技

國家

United States

交易統計

平均交易量

0.69M

交易所

NMS

貨幣

USD

52週範圍

最低 $1.34當前 $2.090最高 $2.17

相關新聞

PR Newswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, HLVX, AVDX on Behalf of Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

查看更多
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BASE, HLVX, AVDX on Behalf of Shareholders
PR Newswire

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of HilleVax, Inc. (NASDAQ: HLVX)

Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for...

查看更多
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of HilleVax, Inc. (NASDAQ: HLVX)
GlobeNewswire

HilleVax Reports Second Quarter 2025 Financial Results

BOSTON, Aug. 06, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. (NASDAQ:HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today reported financial results for the

查看更多
HilleVax Reports Second Quarter 2025 Financial Results
PR Newswire

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HilleVax, Inc.

Rowley Law PLLC is investigating potential securities law violations by HilleVax, Inc. (NASDAQ: HLVX) and its board of directors concerning the...

查看更多
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of HilleVax, Inc.
PR Newswire

Shareholder Alert: The Ademi Firm investigates whether HilleVax, Inc. is obtaining a Fair Price for its Public Shareholders

The Ademi Firm is investigating HilleVax (NASDAQ: HLVX) for possible breaches of fiduciary duty and other violations of law in its transaction with...

查看更多
Shareholder Alert: The Ademi Firm investigates whether HilleVax, Inc. is obtaining a Fair Price for its Public Shareholders
GlobeNewswire

HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right

BOSTON and EMERYVILLE, Calif., Aug. 04, 2025 (GLOBE NEWSWIRE) -- HilleVax, Inc. ("HilleVax" or "the Company") (NASDAQ:HLVX) and XOMA Royalty Corporation ("XOMA Royalty") (NASDAQ:XOMA) announced today they have entered